Hypomethylating agents+venetoclax induction therapy in acute myeloid leukemia unfit for intensive chemotherapy - novel avenues for lesser venetoclax duration and patients with baseline infections from a developing country

Both elderly acute myeloid leukemia (AML) patients and those with baseline infections, when treated with intensive chemotherapy, are associated with high induction mortality. We report 24 patients (16-newly-diagnosed, 8-relapsed/refractory) with AML deemed unfit for intensive chemotherapy (by virtue...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Blood Res
Главные авторы: Mirgh, Sumeet, Sharma, Archana, Shaikh, Mohammad Rizwan Mohammad Anwar, Kadian, Kirti, Agrawal, Narendra, Khushoo, Vishvdeep, Mehta, Pallavi, Ahmed, Rayaz, Bhurani, Dinesh
Формат: Artigo
Язык:Inglês
Опубликовано: e-Century Publishing Corporation 2021
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303019/
https://ncbi.nlm.nih.gov/pubmed/34322294
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы